A study presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer demonstrated a promising pathway toward developing predictive biomarkers for immune checkpoint inhibitors.
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 – Biotech Investments
Sartorius Stedim Biotech SA / Key word(s): 9 Month figures Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 17-Oct-2024 /